Plunkett Research Online: Neuralstem Inc

NEURALSTEM INC (CUR:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Neuralstem, Inc. is development stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs. The firm has developed and maintains a portfolio of patents and patent a.....



Neuralstem Inc
Ticker: CUR
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 301 366-4841
Fax:
Address: 20271 Goldenrod Lane
Germantown, MD 20876 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Stem Cell Therapies
ContactsDescription
Jim ScullyCEO/Chief Accounting Officer
Stanley WestreichDirector
See More
Neuralstem, Inc. is development stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs. The firm has developed and maintains a portfolio of patents and patent a.....See More See More

Auditor: Dixon Hughes Goodman, LLP
Legal Advisor: Silvestre Law Group, P.C.
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: